155 related articles for article (PubMed ID: 27882330)
1. ALDH2 Inhibition Potentiates High Glucose Stress-Induced Injury in Cultured Cardiomyocytes.
Pan G; Deshpande M; Thandavarayan RA; Palaniyandi SS
J Diabetes Res; 2016; 2016():1390861. PubMed ID: 27882330
[TBL] [Abstract][Full Text] [Related]
2. Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes.
Mali VR; Deshpande M; Pan G; Thandavarayan RA; Palaniyandi SS
Cell Signal; 2016 Feb; 28(2):1-6. PubMed ID: 26577527
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 2 inhibition potentiates 4-hydroxy-2-nonenal induced decrease in angiogenesis of coronary endothelial cells.
Roy B; Palaniyandi SS
Cell Biochem Funct; 2020 Apr; 38(3):290-299. PubMed ID: 31943249
[TBL] [Abstract][Full Text] [Related]
4. 4-hydroxy-2-nonenal decreases coronary endothelial cell migration: Potentiation by aldehyde dehydrogenase 2 inhibition.
Roy B; Sundar K; Palaniyandi SS
Vascul Pharmacol; 2020 Aug; 131():106762. PubMed ID: 32585188
[TBL] [Abstract][Full Text] [Related]
5. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2.
Jiang WB; Zhao W; Chen H; Wu YY; Wang Y; Fu GS; Yang XJ
Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):303-311. PubMed ID: 29047162
[TBL] [Abstract][Full Text] [Related]
6. A role for aldehyde dehydrogenase (ALDH) 2 in angiotensin II-mediated decrease in angiogenesis of coronary endothelial cells.
Roy B; Palaniyandi SS
Microvasc Res; 2021 May; 135():104133. PubMed ID: 33428883
[TBL] [Abstract][Full Text] [Related]
7. [Mitochondrial aldehyde dehydrogenase 2 protects against high glucose-induced injury in neonatal rat cardiomyocytes by regulating CaN-NFAT3 signaling pathway].
Guo J; Kang P; Zhu L; Sun S; Tao M; Zhang H; Tang B
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1288-1293. PubMed ID: 30514674
[TBL] [Abstract][Full Text] [Related]
8. Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic-Reperfusion Injury Due to 4-Hydroxy-2-Nonenal Induced Coronary Endothelial Cell Damage.
Pan G; Roy B; Palaniyandi SS
J Am Heart Assoc; 2021 Sep; 10(18):e021140. PubMed ID: 34482710
[TBL] [Abstract][Full Text] [Related]
9. A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy.
Guo Y; Yu W; Sun D; Wang J; Li C; Zhang R; Babcock SA; Li Y; Liu M; Ma M; Shen M; Zeng C; Li N; He W; Zou Q; Zhang Y; Wang H
Biochim Biophys Acta; 2015 Feb; 1852(2):319-31. PubMed ID: 24874076
[TBL] [Abstract][Full Text] [Related]
10. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
11. Alterations in necroptosis during ALDH2‑mediated protection against high glucose‑induced H9c2 cardiac cell injury.
Fang T; Cao R; Wang W; Ye H; Shen L; Li Z; Hu J; Gao Q
Mol Med Rep; 2018 Sep; 18(3):2807-2815. PubMed ID: 30015964
[TBL] [Abstract][Full Text] [Related]
12. ULK1-regulated autophagy: A mechanism in cellular protection for ALDH2 against hyperglycemia.
Liu M; Lu S; He W; Zhang L; Ma Y; Lv P; Ma M; Yu W; Wang J; Zhang M; Zhang Y; Li Y
Toxicol Lett; 2018 Feb; 283():106-115. PubMed ID: 29128638
[TBL] [Abstract][Full Text] [Related]
13. Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.
Mali VR; Ning R; Chen J; Yang XP; Xu J; Palaniyandi SS
Exp Biol Med (Maywood); 2014 May; 239(5):610-8. PubMed ID: 24651616
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment.
Kim J; Chen CH; Yang J; Mochly-Rosen D
J Biomed Sci; 2017 May; 24(1):33. PubMed ID: 28532411
[TBL] [Abstract][Full Text] [Related]
15. Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors.
Omran Z
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056791
[TBL] [Abstract][Full Text] [Related]
16. Precision medicine approach: Empagliflozin for diabetic cardiomyopathy in mice with aldehyde dehydrogenase (ALDH) 2 * 2 mutation, a specific genetic mutation in millions of East Asians.
Pan G; Deshpande M; Pang H; Palaniyandi SS
Eur J Pharmacol; 2018 Nov; 839():76-81. PubMed ID: 30240795
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites.
Nene A; Chen CH; Disatnik MH; Cruz L; Mochly-Rosen D
J Biomed Sci; 2017 Jan; 24(1):3. PubMed ID: 28056995
[TBL] [Abstract][Full Text] [Related]
18. Is the mechanism of nitroglycerin tolerance associated with aldehyde dehydrogenase activity? A contribution to the ongoing discussion.
Bilska-Wilkosz A; Kotańska M; Górny M; Filipek B; Iciek M
Acta Biochim Pol; 2019 Dec; 66(4):627-632. PubMed ID: 31883320
[TBL] [Abstract][Full Text] [Related]
19. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
[TBL] [Abstract][Full Text] [Related]
20. Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors.
Wang NN; Wang LH; Li Y; Fu SY; Xue X; Jia LN; Yuan XZ; Wang YT; Tang X; Yang JY; Wu CF
Exp Cell Res; 2018 Jan; 362(1):72-82. PubMed ID: 29155365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
